Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. (MRVI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mrvi · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Buy
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$5.25
+4.3% upside
Low
$4.50
Median: $5.25 · Last Close: $5.03
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$5.25
4.3% upside
High Target
$6
19.2%
Low Target
$4.5
-10.6%
Current Price
$5.03
as of today
Based on analyst price targets, the MRVI stock price prediction for the next 12 months ranges from $4.5 to $6. The consensus MRVI price forecast of $5.25 implies 4.3% upside from the current price of $5.03.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.28 | ↑ 5.00% |
1-day model range: $5.22–$5.35. Peak: $5.35 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -40.6% |
| 2028 | $2 | -53.9% |
| 2029 | $2 | -59.5% |
| 2030 | $2 | -62.3% |
| 2031 | — | -63.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MRVI · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-12-15 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-08-12 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-08-12 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-05-13 | Baird | Maintains | Neutral→Neutral |
| 2025-05-13 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-03-25 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-03-21 | UBS | Maintains | Neutral→Neutral |
| 2025-03-03 | B of A Securities | Maintains | Buy→Buy |
| 2025-02-26 | Baird | Downgrade ↓ | Outperform→Neutral |
Wall Street analysts have recently issued updated ratings on Maravai LifeSciences Holdings, Inc. (MRVI) stock. Of the recent 72 rating actions, 1 were upgrades and 9 were downgrades. 14 analysts currently cover MRVI.
Analyst Recommendation Trends
MRVI analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$210M
↓ 13.5% YoY
Revenue Next Year
$226M
↑ 7.3% YoY
EPS This Year
$-0.11
EPS Next Year
$-0.09
↓ 19.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MRVI EPS of $-0.11 for the current fiscal year, based on estimates from 5 analysts. The MRVI revenue forecast is $210M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MRVI stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MRVI price target is $5.25 (+4.3% upside), with an analyst consensus of Buy.
The MRVI short-term stock prediction for tomorrow is $5.28 (+5.00%). The MRVI stock price prediction for 2027 estimates an average of $3. The MRVI stock prediction for 2030 projects a range of $2–$2.
Maravai LifeSciences Holdings, Inc. trades on NASDAQ under the ticker MRVI. The MRVI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
MRVI forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month MRVI price target is $5.25, with a high forecast of $6.00 and a low of $4.50. The median price target is shown in the chart above when available. This implies +4.3% potential upside from the current price of $5.03.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.